Lyxumia 10 micrograms solution for injection

Lyxumia is a brand-name prescription medication that’s used to treat type 2 diabetes. Lyxumia 10 micrograms solution for injection

Home | Lixisenatide Solution For Injection

Lyxumia (Lixisenatide) Solution For Injection Price India Delhi Ahmedabad Bengaluru Chennai Kolkata Mumbai
Lyxumia 10 micrograms solution for injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Overseas Patient/ Export inquires.

Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Lyxumia 10 micrograms solution for injection

Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes.

Lyxumia is a diabetes medicine that contains the active substance lixisenatide. It is available as a solution for injection in a pre‑filled pen that provides either 10 micrograms or 20 micrograms of lixisenatide in each dose. Lyxumia is used in adults who have type 2 diabetes to control their blood glucose (sugar) level. It is used together with diabetes medicines taken by mouth and/or basal insulin (long-acting insulin) in patients whose blood glucose levels are not adequately controlled by these medicines together with diet and exercise. The medicine can only be obtained with a prescription.

Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes. In the European Union, its use is limited to complementing insulin therapy. As of 2017 it is unclear if they affect a person’s risk of death. It is provided in an autoinjector containing fourteen doses and is injected subcutaneously. The European Commission granted a marketing authorisation valid throughout the European Union for Lyxumia on 1 February 2013.

Drug (Brand / Generic): Lyxumia 10 micrograms solution for injection / Lixisenatide
Current Indications: type 2 diabetes
Marketed by:: Sanofi Winthrop Industrie
Approval Date: 2013

Available as (Form & Strength): 10 micrograms solution for injection

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India is certified pharmaceutical facilitator / supplier / importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “Lyxumia 10 micrograms solution for injection

Confirmation of the order for ALyxumia (Lixisenatide) will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.

We have delivered medicines to following cities in India –  Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand Lyxumia (Lixisenatide). The import process requires a valid prescription and an Import License in the Patient’s Name.

For patients from following foreign countries seeking access to Lyxumia (Lixisenatide), they can inquire and find further information by sending their inquiries to ALS.

We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.

Kindly reach out to us for Lyxumia (Lixisenatide) price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.